EXTRAORDINARY AH Teaching from Spiritual Hierarchy
  NEW READERS! Read Here First
  Supporting AH
  Leadership of AbundantHope
  Regional AH Sites
  Other Sites with AH material
  Contact Us
  Becoming A Messiah
  Mission Ideas
  System Busting
  Cleric Letter/English
  Translations of Cleric Letter
  AH Member Writings
  Brian's Poetry
  Telepathic Messages
  Jess Anthony
  Lucia G
  Targeted Messages
  Light Flower
  Changing The Face Of Religion
  - Phoenix Journals - PDF in German
  Candace on Religion
  Other Spiritual Pieces
  Gems from God Like Productions
  Spiritual Nuggets by the Masters
  Phoenix Journals
  Phoenix Journals - PDF
  Telepathic Messages PDF books
  Selections from the Urantia Book
  Illustrations For The Urantia Book
  CMGSN Pieces
  David Crayford and the ITC
  Health and Nutrition
  Podcasts, Radio Shows, Video by AH
  Political Information
  True US History
  Human/Animal Rights
  The Miracle That Is Me
  911 Material
  Books - eBooks
  government email/phone #'s
  Self Reliance
  Alternative News Sources
  Art and Music
  Foreign Sites
  Health and Healing
  Human/Animal Rights
  Vegan Recipes
  Translated Material
  Gekanaliseerde berichten Jess
  Gekanaliseerde berichten Candace
  Gekanaliseerde berichten Anderen
  Canal Jess
  Par Candace
  Other Channels
  Telepathische Nachrichten (Candace)
  Telepathische Nachrichten (Jess)
  Telepathische Nachrichten (div.)
  AH Mitgliederbeiträge (Candace)
  AH Mitgliederbeiträge (Jess)
  Spirituelle Schätze
  Translations - Candace
  Translations - Jess
  Translations - Others
  by Candace
  By Jess
  By Others
  Anfitriones Divinos
  Bitácoras Fénix
  Creadores-de-Alas (WingMakers/Lyricus)
  Escritos de Candace
  Escritos de Otros
  Telemensajes de Candace
  Telemensajes de Jess Anthony
  Telemensajes de Otros
  By Candace
  By Jess
  By Others
  Korean Translations
  Hungarian Translations
  Swedish Translations

[an error occurred while processing this directive]
Health and Nutrition Last Updated: May 12, 2021 - 4:02:46 AM

EU Regulators Call on Pfizer, Moderna, AstraZeneca for More Data on Heart Inflammation, Guillain–Barré Syndrome
By Megan Redshaw
May 12, 2021 - 1:29:48 AM

Email this article
 Printer friendly page Share/Bookmark

May 10th 2021

EMA recommends updates to labels, lists of side effects.

The Defender is experiencing censorship on many social channels. Be sure to stay in touch with the news that matters by subscribing to our top news of the dayIt's free.

EU regulators Friday called on Pfizer and Moderna to provide additional data related to the companies' COVID vaccines and a potential link to heart inflammation, after the agency completed a safety review of all four COVID vaccines authorized for emergency use in the EU.

The European Medicines Agency's safety committee, (PRAC), also asked AstraZeneca for data related to reports of Guillain-Barré syndrome in people who received the AstraZeneca vaccine, and they recommended Pfizer and Johnson & Johnson (J&J) update their labels with side effect warnings.

In a report issued May 7, PRAC disclosed its members were aware of cases of myocarditis and pericarditis following Pfizer vaccination. Regulators said they didn't see an indication the vaccine caused these cases, but as a prevention, PRAC requested Pfizer provide further data, including an analysis of events according to age and gender in its next pandemic summary safety report and will consider if any other regulatory action is needed.

Because Moderna and Pfizer use the same mRNA technology for their vaccines, the committee asked Moderna to monitor for similar cases of heart inflammation.

Myocarditis, or inflammation of the heart muscle, can lead to cardiac arrhythmia and death. Pericarditis is inflammation of the membrane around the heart.

A search in the CDC's Vaccine Adverse Events Reporting System (VAERS) revealed 213 cases of pericarditis and myocarditis reported in the U.S following COVID vaccination. Of the 213 cases reported, 105 cases were attributed to Pfizer, 93 cases to Moderna and 15 cases to Johnson & Johnson's (J&J) COVID vaccine.

On April 27, Reuters reported the U.S. Department of Defense was investigating 14 cases of heart inflammation among people who were vaccinated through the military's health services.

CHD and The Defender Now in 5 Languages - Watch Now

Of the 14 cases, one patient developed myocarditis after their first dose of vaccine. The remaining 13 patients developed myocarditis after their second vaccine doses. Eleven received the Moderna vaccine and three received Pfizer.

Israel's Health Ministry is also examining cases of heart inflammation in people who received Pfizer's COVID vaccine. As The Defender reported April 26, a preliminary report by the committee tasked with monitoring vaccine side effects in Israel identified 62 cases of myocarditis, including two deaths, after recent vaccination with Pfizer. Fifty-five of the cases occurred in men - most between ages 18 and 30.

In the case of AstraZeneca, PRAC said it is examining reports of Guillain-Barré syndrome and asked for more detailed data and an analysis of all reported Guillain-Barré syndrome cases.

Guillain-Barré syndrome is a rare immune disorder in which the body's immune system attacks the nerves resulting in paralysis. It had been previously identified by regulators as a potential adverse side effect that required monitoring following AstraZeneca's shot.

EMA recommends updates to labels, lists of side effects

The EMA's May 7 report also included the recommendation that Pfizer add a new side effect to its product information for people with dermal fillers - soft, gel-like substances injected under the skin.

After reviewing all available evidence, including cases reported to the European database for suspected side effects and data from scientific literature, PRAC said there is at least a "reasonable possibility of a causal association between the vaccine and the reported cases of facial swelling in people with a history of injections with dermal fillers."

The safety committee also said it would update its warning for J&J's COVID vaccine after EU regulators in April identified a link between the shot and blood clots.

Though PRAC said the benefits of the vaccine outweigh the risks, the label will now include advice that patients diagnosed with thrombocytopenia within three weeks of vaccination be actively investigated for signs of thrombosis and that patients who present with thromboembolism within three weeks be evaluated for thrombocytopenia.

Thrombosis with thrombocytopenia syndrome will also be added as an "important identified risk" in the risk management plan for J&J's vaccine. The committee asked the company to provide a plan to further study the possible underlying mechanisms for these events.

Additionally, PRAC looked at clotting risks with Pfizer and Moderna vaccines. Though several cases of low blood platelets and blood clots were identified, the committee concluded that for the moment there does not seem to be any evidence of a safety signal for the mRNA shots.

Utilizing a search criteria that included reports of blood clots associated with blood clotting disorders, VAERS yielded a total of 2,808 reports in the U.S for all three vaccines from Dec. 14, 2020, through April 30. Of the 2,808 cases reported, there were 1,043 reports of blood clotting disorders attributed to Pfizer.

As The Defender reported Monday, a Utah teen remains hospitalized with three blood clots in and near his brain that developed after he received the first dose of Pfizer's COVID vaccine.

On May 7, Pfizer became the first COVID vaccine producer to request full approval by the U.S Food and Drug Administration for ages 16 and up. Pfizer requested priority review, which asks the FDA to take action within six months, compared to 10 months designated under standard review.

The FDA is expected to amend Pfizer's Emergency Use Authorization (EUA) this week to authorize use of the vaccine in adolescents aged 12 to 15. The company announced plans to further expand EUA for its vaccine for children ages 2 to 11 in September.

If approved, Pfizer will be the first experimental vaccine to receive full approval by the FDA.

Subscribe to The Defender - It's Free!




Megan Redshaw is a freelance reporter for The Defender. She has a background in political science, a law degree and extensive training in natural health.


All writings by members of AbundantHope are copyrighted by
©2005-2021 AbundantHope - All rights reserved

Detailed explanation of AbundantHope's Copyrights are found here

Top of Page

Health and Nutrition
Latest Headlines
Biden Administration Takes Steps to Make sex-change Surgery Available As A Healthcare Benefit for Military Veterans
Pfizer & Moderna Fail To Respond To British Medical Journal About COVID Vaccine Safety Concerns
EU Health Official says Countries Should Stop Giving AstraZeneca Vaccine to Those Aged 60 and up
COVID, Ivermectin and the Crime of the Century
Covid-19 Vaccines Are Said to Be Free For The “health of the nation,”
Four Healthy British Airways Pilots Die in One Week – Airline Says No Link to Covid-19 Vaccine
The Unethical History of Big Pharma, And Why They Can’t Be Trusted On Anything
Russia’s Unprecedented Compulsory Vaccination Push Divides Society
Bizarre Situations Arise As The Result of The Artificial Reproduction Industry
Corruption Is Profitable. But Does It Have To Be This Profitable?
‘Doctors for COVID Ethics’ Call Out European Medicines Agency Over Vaccine Safety Oversights
What Do You Get When You Cross COVIDCon With Communism?
High Levels of Toxic ‘Forever Chemicals’ Found in More Than Half of Cosmetics Sold in U.S.
Hundreds Awaiting a Decision From The Govt’s ‘stingy’ Vaccine Injury Compensation Program
Many U.S. Cities Are Already Starting To Resemble Post-Apocalyptic Cesspools As America’s Collapse Accelerates
Political Satirist Takes Up the Fight Against Tyranny
As a GP In The NHS I Witnessed first-hand The Catastrophic Way Matt Hancock Failed The Old And Vulnerable in Care Homes
The Covid Vaccine and Depopulation; The Beginning of the Trail